Julie Ann Paleen Aronow, MFT Psychologist - Counseling Medicare: Not Enrolled in Medicare Practice Location: 150 W 1st St Ste 270, New Richmond, WI 54017 Phone: 715-246-4840 |
Steven Matthew Charpentier, PSYD, LP Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 137 E 3rd St, New Richmond, WI 54017 Phone: 715-781-9542 Fax: 715-430-2261 |
News Archive
SCIENTISTS fighting cancer have carried out the first successful trial of the effects of the antibiotic Doxycycline on cancer reoccurrence in patients after surgery.
Amylin Pharmaceuticals, Inc. and Eli Lilly and Company today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has issued a positive opinion in the European Union for the expanded use of BYETTA (exenatide twice-daily) as an add-on therapy to basal insulin, with or without metformin and/or Actos (pioglitazone), for the treatment of type 2 diabetes in adults who have not achieved adequate glycemic control with these agents.
Isobionics has finalized the development of a breakthrough fermentation process for production of its natural Valencene Pure. This product, which is an aroma substance for the food, beverage, flavor and fragrance industry, is now available on a commercial scale. Compared with conventional valencene, which is produced from oranges, it offers the advantage of high purity and constant quality.
Nearly 66 percent of all adverse events experienced by nursing home residents, such as falls, delirium and hallucinations, could be prevented, in part, by monitoring medication more closely. In nursing homes, both registered nurses (RNs) and licensed practical nurses (LPNs) perform medication reconciliation, a safety practice during which health care professionals review patients' medications to reduce the likelihood of preventable adverse drug events.
St. Jude Medical, Inc., a global medical device company, today announced the first patient implant of its 25 mm Portico Transcatheter Aortic Heart Valve using the Transfemoral Delivery System in its ongoing European trial.
› Verified 8 days ago